InvestorsHub Logo
Followers 0
Posts 111
Boards Moderated 0
Alias Born 02/09/2017

Re: Aprilov post# 27314

Wednesday, 07/12/2017 12:35:32 PM

Wednesday, July 12, 2017 12:35:32 PM

Post# of 30351
Not saying that the Human Factors Study is not done or close to being done. In reality, all that the FDA was asking Apricus to do with regard to this study, was provide additional information regarding the proper use of the applicator.

“In November of 2016, the FDA designated Vitaros as a drug-device combination and required Apricus to provide additional information regarding the proper use of the applicator in the planned NDA re-submission,” stated Richard W. Pascoe, Chief Executive Officer.

But in all honesty - Aprilov, and not that I recommend anyone taking casino's word over anything that has to do with Apricus. How much is Matt Beck's word worth? I understand that he is only as good as the information that he is given. But Apricus Management has lied time over time! The last lie? How about the $500 k cash burn per month? They said that in March 2017 and right after that they burned through more cash in 24 days that in the previous 66 days of that quarter - during the first quarter of 2017.

I also had been a proponent of calling the company directly rather that taking somebody's word on a message board. But with this type of management, what good does that do?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SEEL News